Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14499869rdf:typepubmed:Citationlld:pubmed
pubmed-article:14499869lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0018801lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0002651lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C1545588lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C1412387lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:14499869lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:14499869pubmed:issue3lld:pubmed
pubmed-article:14499869pubmed:dateCreated2003-9-22lld:pubmed
pubmed-article:14499869pubmed:abstractTextPossession of the C34T (Glu12Stop) nonsense mutation in the AMP-deaminase 1 (AMPD1) gene has been shown to be associated with improved prognosis in heart failure and ischemic heart disease. The most likely event leading to these clinical effects is a reduced capacity of the AMP deamination pathway and increased production of cardio-protective adenosine. However, since AMPD1 is predominantly expressed in skeletal muscle, the protective effects could be related not only to local cardiac changes, but also to a systemic mechanism. In the present study we evaluated the effect of the C34T mutation on cardiac AMP-deaminase activity and on the systemic changes in adenosine production.lld:pubmed
pubmed-article:14499869pubmed:languageenglld:pubmed
pubmed-article:14499869pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:citationSubsetIMlld:pubmed
pubmed-article:14499869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499869pubmed:statusMEDLINElld:pubmed
pubmed-article:14499869pubmed:monthSeplld:pubmed
pubmed-article:14499869pubmed:issn0008-6363lld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:YacoubMagdi...lld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:SmolenskiRysz...lld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:BirksEmma JEJlld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:KalethaKrysti...lld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:SlominskaEwaElld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:KalsiKameljit...lld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:YuenAda H YAHlld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:RybakowskaIwo...lld:pubmed
pubmed-article:14499869pubmed:authorpubmed-author:JohnsonPhilip...lld:pubmed
pubmed-article:14499869pubmed:issnTypePrintlld:pubmed
pubmed-article:14499869pubmed:day1lld:pubmed
pubmed-article:14499869pubmed:volume59lld:pubmed
pubmed-article:14499869pubmed:ownerNLMlld:pubmed
pubmed-article:14499869pubmed:authorsCompleteYlld:pubmed
pubmed-article:14499869pubmed:pagination678-84lld:pubmed
pubmed-article:14499869pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:meshHeadingpubmed-meshheading:14499869...lld:pubmed
pubmed-article:14499869pubmed:year2003lld:pubmed
pubmed-article:14499869pubmed:articleTitleDecreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.lld:pubmed
pubmed-article:14499869pubmed:affiliationHeart Science Centre, Imperial College at Harefield Hospital, Harefield, Middlesex UB9 6JH, UK.lld:pubmed
pubmed-article:14499869pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14499869pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:14499869pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed